Company Accretive Health, Inc. Nyse
Equities
US00438V1035
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
||
- USD | - |
18/04 | R1 RCM's Q1 Results to Focus on Strategic Alternatives, Change Cyberattack, RBC Says | MT |
11/04 | North American Morning Briefing : Stock Futures -2- | DJ |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Operating Fees
64.6
%
| 1,310 | 72.5 % | 1,456 | 64.6 % | +11.16% |
Modular and Other
30.6
%
| 390 | 21.6 % | 690 | 30.6 % | +76.94% |
Incentive Fees
4.8
%
| 107 | 5.9 % | 108 | 4.8 % | +1.50% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 1,806 | 100.0 % | 2,254 | 100.0 % | +24.79% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Lee Rivas
CEO | Chief Executive Officer | - | 22/22/22 |
Director of Finance/CFO | - | 21/22/21 | |
John Sparby
PSD | President | 48 | 01/04/01 |
Kristina Bourke
COO | Chief Operating Officer | - | - |
Corey Perman
CMP | Compliance Officer | - | 01/15/01 |
Brian Gambs
CTO | Chief Tech/Sci/R&D Officer | - | 01/22/01 |
Joseph Flanagan
BRD | Director/Board Member | 52 | 01/13/01 |
Atif A. Rahim
IRC | Investor Relations Contact | - | - |
Pamela Spikner
AUD | Comptroller/Controller/Auditor | 47 | 01/21/01 |
Logan Johnston
PRN | Corporate Officer/Principal | - | 01/04/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Anthony Tersigni
BRD | Director/Board Member | 74 | 12/19/12 |
David Dill
BRD | Director/Board Member | 55 | 18/21/18 |
Joseph Flanagan
BRD | Director/Board Member | 52 | 01/13/01 |
Jill Smith
BRD | Director/Board Member | 65 | 12/19/12 |
John Henneman
BRD | Director/Board Member | 62 | 16/16/16 |
Ian Sacks
BRD | Director/Board Member | 53 | 16/16/16 |
Anthony Speranzo
CHM | Chairman | 75 | 16/16/16 |
Michael Feiner
BRD | Director/Board Member | 81 | 09/17/09 |
Agnes Scanlan
BRD | Director/Board Member | 66 | 11/21/11 |
Lee Rivas
CEO | Chief Executive Officer | - | 22/22/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 445,964,666 | 155,810,503 ( 34.94 %) | 25,234,975 ( 5.659 %) | 34.94 % |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+14.57% | 80.61B | |
-29.50% | 70.18B | |
+9.86% | 29.12B | |
-11.63% | 16.97B | |
-0.68% | 16.96B | |
-0.58% | 15.26B | |
+4.72% | 12.41B | |
-30.88% | 11.95B | |
-5.84% | 11.93B |
- Stock Market
- Equities
- RCM Stock
- Stock
- Company Accretive Health, Inc.